Withdrawn study sought to ease lymphedema fears in breast cancer patients
NCT ID NCT06672224
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study was designed to see if getting an IV in the arm that had breast cancer surgery increases the risk of lymphedema (arm swelling). Researchers planned to use a special dye called indocyanine green (ICG) and a camera system (SPY angiography) to watch how fluid moves through the arm. The study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Indocyanine Green (ICG)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Phone-Based navigation could boost breast cancer detection in kenya
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple